Patient-Reported Outcome Results From the Open-Label, Randomized Phase III Myeloma X Trial Evaluating Salvage Autologous Stem-Cell Transplantation in Relapsed Multiple Myeloma

PURPOSE: Salvage autologous stem-cell transplantation (sASCT) in patients with multiple myeloma (MM) relapsing after a prior autologous stem-cell transplantation leads to increased remission duration and overall survival. We report a comprehensive study on patient-reported outcomes, including qualit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmedzai, Sam H., Snowden, John A., Ashcroft, Andrew John, Cairns, David Allan, Williams, Cathy, Hockaday, Anna, Cavenagh, Jamie D., Ademokun, Debo, Tholouli, Eleni, Allotey, David, Dhanapal, Vijay, Jenner, Matthew, Yong, Kwee, Cavet, Jim, Hunter, Hannah, Bird, Jennifer M., Pratt, Guy, Parrish, Christopher, Brown, Julia M., Morris, Treen C.M., Cook, Gordon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858007/
https://www.ncbi.nlm.nih.gov/pubmed/30969846
http://dx.doi.org/10.1200/JCO.18.01006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858007/
https://www.ncbi.nlm.nih.gov/pubmed/30969846
http://dx.doi.org/10.1200/JCO.18.01006

Ejemplares similares